Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan M Weiss

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Blood|April 20, 2013
Multiethnic myelomaBrendan M Weiss
Expert Review of Hematology|May 18, 2010
Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myelomaBrendan M Weiss, W Michael Kuehl
Clinical Journal of the American Society of Nephrology : CJASN|July 16, 2016
Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal SignificanceJonathan J Hogan, Brendan M Weiss
Blood|February 25, 2016
Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosisBrendan M Weiss, Sandy W Wong, Raymond L Comenzo
American Journal of Hematology|September 21, 2016
Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibodyMorie A Gertz, Heather J Landau, Brendan M Weiss
American Journal of Hematology|January 12, 2008
The impact of race on outcomes of autologous transplantation in patients with multiple myelomaPramvir S Verma, Robin S Howard, Brendan M Weiss
Kidney International|January 23, 2019
The authors replyJonathan J Hogan, Brendan M Weiss, Laura M Dember
Seminars in Hematology|January 15, 2011
Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: pathogenesis, interventions, and future opportunitiesAlex R Minter, Haley Simpson, Brendan M Weiss, et al.
American Journal of Hematology|June 25, 2010
Multiple myeloma with lacrimal gland amyloidosis and sarcoidosisGregory Brown, Lorraine G Shapeero, Brendan M Weiss, et al.
Leukemia & Lymphoma|October 6, 2016
Impact of metformin on the progression of MGUS to multiple myelomaBen Boursi, Ronac Mamtani, Yu-Xiao Yang, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Blood|April 20, 2013
Multiethnic myelomaBrendan M Weiss
Expert Review of Hematology|May 18, 2010
Advances in understanding monoclonal gammopathy of undetermined significance as a precursor of multiple myelomaBrendan M Weiss, W Michael Kuehl
Clinical Journal of the American Society of Nephrology : CJASN|July 16, 2016
Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal SignificanceJonathan J Hogan, Brendan M Weiss
Blood|February 25, 2016
Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosisBrendan M Weiss, Sandy W Wong, Raymond L Comenzo
American Journal of Hematology|September 21, 2016
Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibodyMorie A Gertz, Heather J Landau, Brendan M Weiss
American Journal of Hematology|January 12, 2008
The impact of race on outcomes of autologous transplantation in patients with multiple myelomaPramvir S Verma, Robin S Howard, Brendan M Weiss
Kidney International|January 23, 2019
The authors replyJonathan J Hogan, Brendan M Weiss, Laura M Dember
Seminars in Hematology|January 15, 2011
Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: pathogenesis, interventions, and future opportunitiesAlex R Minter, Haley Simpson, Brendan M Weiss, et al.
American Journal of Hematology|June 25, 2010
Multiple myeloma with lacrimal gland amyloidosis and sarcoidosisGregory Brown, Lorraine G Shapeero, Brendan M Weiss, et al.
Leukemia & Lymphoma|October 6, 2016
Impact of metformin on the progression of MGUS to multiple myelomaBen Boursi, Ronac Mamtani, Yu-Xiao Yang, et al.
Pageof 6